Astrazeneca Share Price (AZN)

[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Shares Traded Last Trade
  6.00 0.07% 8,274.00 5,337,790 16:35:06
Bid Price Offer Price High Price Low Price Open Price
8,274.00 8,277.00 8,300.00 8,174.00 8,271.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 19,468.19 2,864.24 178.47 47.1 128,174
Last Trade Time Trade Type Trade Size Trade Price Currency
18:24:53 O 5,084 8,274.00 GBX
Related Shares
Glaxosmithkline (GSK), Hikma Pharmaceuticals (HIK), Motif Bio (MTFB), Bermele (BERM)

Astrazeneca (AZN) Latest News (11)

Astrazeneca News

Date Time Source Headline
02/8/202115:00UKREGAstraZeneca PLC Total Voting Rights
02/8/202113:00ALNCPressure grows to recall MPs to debate UK vaccine passports proposal
02/8/202108:37ALNCAstraZeneca's Saphnelo gets FDA approval in US for systemic lupus
02/8/202107:35DJNAstraZeneca's Saphnelo Approved in U.S. for Moderate-to-Severe SLE
02/8/202107:00UKREGAstraZeneca PLC Saphnelo approved in the US for SLE
29/7/202109:40ALNCTOP NEWS: AstraZeneca Covid jab sales top USD1 billion in first half
29/7/202109:20DJNAstraZeneca Lifts 2021 Guidance After Alexion Acquisition; Posts Lower 2Q..
29/7/202108:05DJNAstraZeneca 2Q Net Profit Dropped Despite Higher Revenue; Raises Guidance
29/7/202107:00UKREGAstraZeneca PLC AZN: H1 2021 Results
27/7/202112:56ALNCAstraZeneca partners with Regeneron to research obesity treatment
More Astrazeneca News
Astrazeneca Investors    Astrazeneca Takeover Rumours
Smart Money!
AZN is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 EP GLOBAL OPPORTUNITIES TRUST PLC 2.30% 2020-11-30
 BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC 6.60% 2021-06-30
 BMO CAPITAL AND INCOME INVESTMENT TRUST PLC 4.30% 2021-06-30
 JUPITER UK GROWTH INVESTMENT TRUST PLC 3.70% 2021-07-30
 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC 4.80% 2021-06-30

Astrazeneca (AZN) Discussions and Chat

Astrazeneca Forums and Chat

Date Time Title Posts
01/8/202109:22AstraZeneca4,902
26/6/202119:47EU and AZN 1
24/6/202116:39ASTRAZENECA, MSD PROSTATE CANCER DRUG GETS CHINA GREEN LIGHT1
20/6/202112:00INDIA'S COVID DEATH RATE IS 278 PER 1 MILLION..UK'S IS 1876..THINK ABOUT IT-
25/5/202115:17Alexion deal7

Add a New Thread

Astrazeneca (AZN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:30:368,274.005,084420,650.16O
17:30:368,274.00171,01514,149,781.10O
17:30:258,274.002,528209,166.72O
17:26:588,271.0065,6055,426,189.55O
17:25:338,271.0065,6055,426,189.55O
View all Astrazeneca trades in real-time

Astrazeneca (AZN) Top Chat Posts

DateSubject
02/8/2021
09:20		Astrazeneca Daily Update: Astrazeneca Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 8,268p.
Astrazeneca Plc has a 4 week average price of 8,142p and a 12 week average price of 7,556p.
The 1 year high share price is 8,848p while the 1 year low share price is currently 6,736p.
There are currently 1,549,116,129 shares in issue and the average daily traded volume is 2,369,137 shares. The market capitalisation of Astrazeneca Plc is £128,173,868,513.46.
Read Full Thread
Reply
01/8/2021
09:09		waldron: CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported second-quarter profit of $550 million. The Cambridge, Britain-based company said it had profit of 21 cents per share. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The pharmaceutical posted revenue of $8.22 billion in the period. Astrazeneca shares have increased 14% since the beginning of the year. The stock has climbed almost 1% in the last 12 months. This story was generated by Automated Insights (Http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at Https://www.zacks.com/ap/AZN
Read Full Thread
Follow
Reply
29/6/2021
10:44		philanderer: Drug breakthroughs to drive AstraZeneca, says Berenberg Breast cancer drug Enhertu is expected to provide further upside in AstraZeneca (AZN) shares, says broker Berenberg. Analyst Luisa Hector retained her ‘buy’ recommendation and £95 target price on the shares, which closed up 2%, or 167p, at £86.66 on Monday. Hector said the share price had ‘largely recovered from its winter woes when the company’s Covid-19 vaccine and the proposed Alexion acquisition led to downward pressure’. She is expecting AstraZeneca to continue delivering returns on its research and development programme, in particular the investment in Enhertu, a medicine used to treat breast cancer that has spread to other parts of the body or cannot be removed by surgery. ‘Positive data readouts in the second half from pipeline assets such as Enhertu should drive further upside in the AstraZeneca share price as probabilities of success increase and sales are subject to upward revisions,’ she said. HTTPS://citywire.co.uk/funds-insider/news/expert-view-astrazeneca-jd-sports-petrofac-greggs-and-alpha-financial/a1524218?section=funds-insider&_ga=2.33020406.917469266.1624959738-1068178417.1624959738#i=2
Read Full Thread
Follow
Reply
09/6/2021
19:53		arja: bad news announcement and AZN share price rockets - hard to understand the market at times !
Read Full Thread
Follow
Reply
26/5/2021
09:49		beckers2008: N100, More like, AZN will confront and prove that the contract the EU signed was 'best efforts' as AZN were contractually committed to the UK. Now it has gone to court, AZN can show what a shambles the EU procurement process is. The EU will not come out of this in a good light, that is assured!
Read Full Thread
Follow
Reply
12/5/2021
09:56		stutes: The Alexion deal received shareholders' approval. The drop in the share price, initially put down to the price and fears over integration, remains in part. I think it could take a few quarters before the City warms to the deal?
Read Full Thread
Follow
Reply
05/5/2021
15:04		stutes: I have seen how the share AZN price reacted to Alexion deal and I will vote against the deal. I will not reward the City or speculators by voting the deal through.
Read Full Thread
Follow
Reply
04/5/2021
10:36		stutes: I note how Alexion adr is around $170 level - below bid price. I don't buy into the recent increase while AZN share price remains below £85 to £100 range. Alexion needs AZN's cash to fund future r&d - time to renegotiate the bid price ?
Read Full Thread
Follow
Reply
30/4/2021
11:33		beckers2008: FY guidance of $4.75/$5 per share gives a forward PE of around 11 at current share price of $53. Can't see AZN being as low as $53 in 10 months time and should have an impact here?
Read Full Thread
Follow
Reply
14/4/2021
13:02		anony mous: Tbh the more countries who ban this vaccine then better for azn.The share price would rocket.Azn probably thinking why they bothered helping for free.
Read Full Thread
Follow
Reply
23/3/2021
14:27		essentialinvestor: In terms of AZN, sweet spot for buying £66-68, attractive under £71, imv obvs If you want to trade it while the vaccine news dominates, sell a few a good news day, buy back on a bad. However, there is less than 0 vaccine premium in the AZN SP, these are sentiment moves only. What's relevant to the share price is Alexion acquisition news and pipeline progression/approvals.
Read Full Thread
Follow
Reply
Astrazeneca share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210802 19:58:28